Let’s take a look at some of the stocks making the biggest moves during intraday trading. Ultragenyx Pharmaceutical – Shares plummeted more than 40% after Ultragenyx announced that its bone disease treatment settrusumab performed worse than expected in two trials. “Both studies failed to meet their primary endpoint of reducing annual clinical fracture rates compared to placebo or bisphosphonates,” the company said in a statement. NEWMONT, Freeport-McMoRan – The mining company’s stock price fell along with the prices of gold and silver in midday trading Monday. Newmont fell more than 5% and Freeport-McMoRan fell 2%. The Global X Silver Miners ETF (SIL) fell more than 4%. Silver prices rose above $80 an ounce in overnight trading and were down more than 7% on Monday, while gold was down more than 4%. Energy stocks – Energy company stocks rose as oil prices rose more than 2%. Investors weighed the possibility of peace talks in Ukraine alongside possible supply disruptions in the Middle East. Shares of Diamondback Energy and Devon Energy rose nearly 2%, making the S&P 500’s energy sector the index’s top gainer. DigitalBridge — a private equity firm that invests in data centers and other assets soared 10%. Japan’s SoftBank announced on Monday that it had signed a deal to acquire Digital Bridge for $4 billion. Nvidia — The chipmaker fell nearly 2%. The stock saw some of its gains from last week after NVIDIA acquired the assets of AI chip startup Groq for about $20 billion in the largest deal ever, CNBC reported. The stock rose 5.3% last week. Praxis Precision Medicines — Shares of the clinical-stage biopharmaceutical company rose 13% after BTIG announced the stock as a top candidate for 2026. The company also raised its price target from $507 to $843, implying an upside of more than 213% for the stock. AXT — AXT fell about 4% after the semiconductor components maker announced Monday that it will issue more than 7 million shares of common stock in an initial public offering. The shares are priced at $12.25 per share and have a combined value of approximately $87 million. —CNBC’s Liz Napolitano contributed reporting.
